Published in J Neural Transm (Vienna) on January 01, 1996
Lithium suppression of tau induces brain iron accumulation and neurodegeneration. Mol Psychiatry (2016) 1.38
GSK-3 in Neurodegenerative Diseases. Int J Alzheimers Dis (2011) 0.97
Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens. J Neurochem (2016) 0.75
Cortical localization of dopamine D4 receptors in the rat brain--immunocytochemical study. J Physiol Pharmacol (2000) 1.04
Determination of the electric field gradient asymmetry from 2D nutation NQR spectra of 75As nuclei in oriented samples of As2Se3 semiconductor. Solid State Nucl Magn Reson (2007) 0.97
Desipramine induces yawning behaviour in rats. Neuropharmacology (1986) 0.93
WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801. Neuropsychopharmacology (2000) 0.89
Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interaction with estrogen receptor signaling. Neuroscience (2008) 0.87
Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning. Neuroscience (2008) 0.87
GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids (1998) 0.85
Behavioral pharmacology of sigma-ligands. Pharmacopsychiatry (2004) 0.84
Evidence that conditioned stress enhances outflow of dopamine in rat prefrontal cortex: a search for the influence of diazepam and 5-HT1A agonists. Synapse (1996) 0.83
Stimulation of food intake following opioid microinjection into the nucleus accumbens septi in rats. Peptides (1987) 0.82
Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex. Eur J Pharmacol (1996) 0.82
Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex. Br J Pharmacol (2001) 0.82
Maternal separation affects the number, proliferation and apoptosis of glia cells in the substantia nigra and ventral tegmental area of juvenile rats. Neuroscience (2010) 0.82
Glutamatergic neurons of rat medial prefrontal cortex innervating the ventral tegmental area are positive for serotonin 5-HT1A receptor protein. J Physiol Pharmacol (2007) 0.81
NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity. J Neural Transm (Vienna) (1999) 0.80
c-Fos proteins, induced by the serotonin receptor agonist DOI, are not expressed in 5-HT2A positive cortical neurons. Brain Res Mol Brain Res (1999) 0.80
A search for colocalization of mglula receptors with CRF or NPY in the rat brain amygdala. Folia Histochem Cytobiol (2002) 0.79
A search for colocalization of serotonin 5-HT2A and 5-HT1A receptors in the rat medial prefrontal and entorhinal cortices--immunohistochemical studies. J Physiol Pharmacol (2008) 0.79
Functional supersensitivity to the alpha 1-adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by beta-down-regulation. Neuropharmacology (1987) 0.78
The corticosterone synthesis inhibitor metyrapone decreases dopamine D1 receptors in the rat brain. Neuroscience (1997) 0.78
The impact of maternal separation on the number of tyrosine hydroxylase-expressing midbrain neurons during different stages of ontogenesis. Neuroscience (2011) 0.78
5-HT1A receptors mediate detrimental effects of cocaine on long-term potentiation and expression of polysialylated neural cell adhesion molecule protein in rat dentate gyrus. Neuroscience (2009) 0.78
Enhancement by ipsapirone of dopamine release in the rat striatum. Pol J Pharmacol (1993) 0.78
Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens. Eur J Pharmacol (1987) 0.78
The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. J Neural Transm (Vienna) (1996) 0.78
Effect of chronic mild stress and prolonged treatment with imipramine on the levels of endogenous Met-enkephalin in the rat dopaminergic mesolimbic system. Pol J Pharmacol (1997) 0.77
Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors. Pol J Pharmacol (1998) 0.77
DOI, an agonist of 5-HT2A/2C serotonin receptor, alters the expression of cyclooxygenase-2 in the rat parietal cortex. J Physiol Pharmacol (2002) 0.77
Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-beta-carbolines. Pharmazie (1993) 0.77
The role of the GABA mechanisms of the globus pallidus in mediating catalepsy, stereotypy and locomotor activity. Pharmacol Biochem Behav (1984) 0.77
Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens. J Pharm Pharmacol (1985) 0.77
The effect of prolonged administration of lithium on the level of dopamine D2 receptor mRNA in the rat striatum and nucleus accumbens. Acta Neurobiol Exp (Wars) (1996) 0.77
Metyrapone, an inhibitor of corticosterone synthesis, blocks the kainic acid-induced expression of HSP 70. Synapse (2000) 0.76
Cocaine enhances ST8SiaII mRNA expression and neural cell adhesion molecule polysialylation in the rat medial prefrontal cortex. Neuroscience (2011) 0.76
Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: an immunohistochemical study. Brain Res Mol Brain Res (2000) 0.76
Single doses of MK-801, a non-competitive antagonist of NMDA receptors, increase the number of 5-HT1A serotonin receptors in the rat brain. Brain Res (1997) 0.76
[The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia]. Psychiatr Pol (2000) 0.75
Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus--impact of acute and chronic cocaine. J Physiol Pharmacol (2008) 0.75
MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors. Pol J Pharmacol (1997) 0.75
[Elimination of practolol in uremia]. Wiad Lek (1980) 0.75
The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.75
The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens. Eur J Pharmacol (1988) 0.75
Effect of EMD 57445, the selective sigma receptor ligand, on the turnover and release of dopamine. Pol J Pharmacol (1998) 0.75
Prolonged treatment with antidepressants increases the 5-HT1A-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding. Acta Physiol Hung (1996) 0.75
Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity. Drug Des Discov (1994) 0.75
Oxaprotiline enantiomers given repeatedly and brain alpha-adrenoceptors. J Neural Transm Gen Sect (1990) 0.75
[Distribution of dopamine D1 receptors in the paraventricular nucleus of the rat hypothalamus and their colocalization with phosphorylated forms of CREB protein]. Folia Med Cracov (2000) 0.75
The importance of timing for the action of alpha 1- or beta-agonists: possible relationship with the density of [3H]prazosin and [3H]dihydroalprenolol binding sites. Eur J Pharmacol (1985) 0.75
Imipramine increases the 5-HT1A receptor-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding. Eur J Pharmacol (1996) 0.75